Register
Sign In
login
Home
Documents
Browse All »
All Docs
Docstore
Legal
Business
Personal Finance
Technology
Education
Jobs & Careers
Tax
Real Estate
Current Events
Politics & History
Guides
Science
Entertainment
Health & Fitness
Medicine
Conferences
Art & Literature
Lifestyle
Travel
Templates
Resources
Browse All »
Premium Documents
Document Packages
Courses
Videos
Licenses & DBAs
Upload
Share Documents
Sell Documents
Premium
NEW
DocStore
All Documents
DocStore
Legal
Business
Personal Finance
Technology
Education
Jobs & Careers
Tax
Real Estate
Current Events
Politics & History
Guides
Science
Entertainment
Health & Fitness
Medicine
Conferences
Art & Literature
Lifestyle
Travel
Templates
DocStore
The Premier Marketplace to Buy and Sell Professional Documents
DocStore Search:
all docs
Academia
Agreements
Books
Business Resources
Legal Forms
Periodicals
Research Reports
Templates
DocStore
»
ICD Research
most recent
most viewed
price
alphabetically
Partners:
all partners
LegalZoom
FindLegalForms
MorganJames Publishing
BarnesReports
World Market Intelligence
Canadean
Business Review Online
ICD Research
John Wiley & Sons, Inc.
Wright Investors' Service
ReadyBuiltForms
LegalAgreements.com
Career Press
GlobalData
demandmetric.com
Vertex42.com
TechCrunch Reports
PeakStrategy
ProQuest LLC
MegaDox.com
DocstocPremium
Interpret LLC
View All Categories
Per Page:
15
25
50
«
1
2
3
4
5
6
7
...
34
Next »
The Yokohama Rubber Company, Limited: Consumer Products Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "The Yokohama Rubber Company, Limited: Consumer Products - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "The Yokohama Rubber Company, Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "The Yokohama Rubber Company, Limited" for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance and competitive benchmarking. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "The Yokohama Rubber Company, Limited" • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights The Yokohama Rubber Company, Limited (Yokohama) is one of the leading companies in the global tire industry. The company along with its subsidiaries is involved in the manufacturing of tires, hoses, sealants and adhesives, aerospace produc
Milliken & Company, Inc: Textiles Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Milliken & Company, Inc: Textiles - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Milliken & Company, Inc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Milliken & Company, Inc" for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • The profile also contains information on business operations, company history, major products and services, key employees. Reasons To Buy • Quickly enhance your understanding of "Milliken & Company, Inc" • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Milliken & Company, Inc. (Milliken) is one of the leading private textile and chemical companies in the world. The company is into manufacturing of automotive fabrics, carpets, apparels, wall coverings, and mattresses. In addition, the company is involved in providing specialty, technical and industrial textiles and dust control products. Milliken produces a variety of fabric, chemical and yarn products
J D Wetherspoon plc: Leisure and Arts Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "J D Wetherspoon plc: Leisure and Arts - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "J D Wetherspoon plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "J D Wetherspoon plc" for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance and competitive benchmarking. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "J D Wetherspoon plc" • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights J D Wetherspoon plc (Wetherspoon) owns and operates a chain of public houses throughout the UK. The company operates individually designed pubs under different trade names. Wetherspoon operates Lloyds No.1 labeled bars and Wetherspoon hotels apart from operating pubs. The company offers all day menu across
Hutchison Telecommunications (Australia) Limited: Technology and Communications Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Hutchison Telecommunications (Australia) Limited: Technology and Communications - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Hutchison Telecommunications (Australia) Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Hutchison Telecommunications (Australia) Limited" for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance. • The profile also contains information on business operations, company history, major products and services, key employees. Reasons To Buy • Quickly enhance your understanding of "Hutchison Telecommunications (Australia) Limited" • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Hutchison Telecommunications (Australia) Limited (HTAL) is a holding company that holds a 50.00% stake in Vodafone Hutchison Australia Pty Limited (VHA), which provides wireless telecom services and several other value added services un
Genting Berhad: Leisure and Arts Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Genting Berhad: Leisure and Arts - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Genting Berhad" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Genting Berhad" for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance and competitive benchmarking. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Genting Berhad" • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Genting Berhad (Genting) is an investment holding and management company based in Malaysia. The company operates in the leisure and hospitality, power generation, property development, oil palm plantations, biotechnology, oil and gas business segments. Genting principally conducts business operations through its subsidiaries:
Crucell N.V.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Crucell N.V.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Crucell N.V." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Crucell N.V." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Crucell N.V." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Crucell N.V. (Crucell) is a biopharmaceutical company focusing on research and development, manufacturing, and marketing of drugs for the treatment and prevention of infectious diseases. The company operates as a center for vaccines within the Johnson & Johnson pharmaceuticals group. Crucell's product line includes vaccines, proteins and antibodies.
Cephalon, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Cephalon, Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Cephalon, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Cephalon, Inc." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • The profile also contains information on business operations, company history, major products and services, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Cephalon, Inc." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Cephalon, Inc. (Cephalon), is a biopharmaceutical company that specializes in the research, development and marketing of innovative therapeutic products. The company develops products for the treatment of cancer, pain, central nervous system (CNS), and inflammatory disease. Its product portfolio includes modafinil tablets, fentanyl buccal tablets, arsenic trioxide injections, tiagabine hydrochloride , mo
BNP Paribas SA: Financial Services Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "BNP Paribas SA: Financial Services - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "BNP Paribas SA" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "BNP Paribas SA" for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance and competitive benchmarking. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "BNP Paribas SA" • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights BNP Paribas SA (BNP Paribas) is a European leader in global banking and financial services. The company operates in three core businesses: Retail Banking, Asset Management and Services, and Corporate and Investment Banking. Retail Banking includes French retail banking, BNL Banca Commerciale in Italy, BancWest, retail bankin
Apria Healthcare Group Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Apria Healthcare Group Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Apria Healthcare Group Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Apria Healthcare Group Inc." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Apria Healthcare Group Inc." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Apria Healthcare Group Inc. (Apria) is a leading provider of integrated home healthcare products and services. The company provides respiratory therapy, home medical equipment (HME) and home infusion therapy and enteral nutrition services across the US. The company serves more than two million patients on an annual basis in all 50 states
Avid Technology, Inc.: Technology and Communications Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Avid Technology, Inc.: Technology and Communications - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Avid Technology, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Avid Technology, Inc." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance and competitive benchmarking. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Avid Technology, Inc." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Avid Technology, Inc. (Avid) is one of the leading providers of digital media content creation solutions. The company develops, markets and sells a wide range of software and hardware products. Some of its major products include digital audio work stations, home music creations, handhel
United Parcel Service, Inc.: Transport and Logistics Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "United Parcel Service, Inc.: Transport and Logistics - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "United Parcel Service, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "United Parcel Service, Inc." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "United Parcel Service, Inc." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights United Parcel Service, Inc. (UPS) is a provider of logistics and supply chain solutions. The company provides logistics, distribution, transportation and freight services through air, sea, ground and rail. It also provides freight forwarding, international trade management, customs brokerage, fina
Microsoft Corporation: Technology and Communications Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Microsoft Corporation: Technology and Communications - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Microsoft Corporation" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Microsoft Corporation" for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance and competitive benchmarking. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Microsoft Corporation" • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Microsoft Corporation (Microsoft) is one of the leading providers of software and storage products and services. The company designs, develops, manufactures and markets software and hardware products. It also also provides consulting, and product and solution support services. Major sof
Dell Inc.: Technology and Communications Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Dell Inc.: Technology and Communications - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Dell Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Dell Inc." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance and competitive benchmarking. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Dell Inc." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Dell Inc. (Dell) designs, develops, manufactures, markets, and supports information technology systems. The company's product portfolio includes laptops, desktops, workstations, networking, servers, storage devices, printers, software products and computer peripherals. Dell also provides a range of consulting services to enhance the
Biogen Idec Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "Biogen Idec Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Biogen Idec Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Biogen Idec Inc." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Biogen Idec Inc." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Biogen Idec Inc. (Biogen) is a leading biotechnology company focusing on the development, manufacturing and commercialization of therapies used in the areas of oncology, neurology, immunology and cardiology. It offers products to address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's diseas
BioMarin Pharmaceutical Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report
$125.00
$125.00
From:
ICD Research
Document Overview:
Synopsis ICD Research's "BioMarin Pharmaceutical Inc.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "BioMarin Pharmaceutical Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "BioMarin Pharmaceutical Inc." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance and competitive benchmarking. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "BioMarin Pharmaceutical Inc." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights BioMarin Pharmaceutical Inc. (BioMarin) develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Its principal product portfolio includes four approved products Naglazyme, Aldurazyme, and Kuvan and Firdapse. The
Per Page:
15
25
50
«
1
2
3
4
5
6
7
...
34
Next »
The best place to buy premium content from trusted sellers.
Partner with us to sell your content.
Featured Partners
LegalZoom
John Wiley & Sons
Random House
Career Press
McGraw-Hill
Vertex42
DemandMetric
FindLegalForms
OECD